Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is a leading global provider of analytical instruments, laboratory equipment, chemicals, and services. The company operates through four main segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment supplies reagents and instruments for biological research, drug discovery, and disease diagnosis, serving various markets including pharmaceutical and biotechnology. The Analytical Instruments segment offers tools and consumables for laboratory and field applications across multiple sectors, including environmental and industrial. Specialty Diagnostics focuses on immunodiagnostic products and medical research tools, while the Laboratory Products and Services segment provides essential laboratory equipment and consumables. With a commitment to advancing scientific discovery, Thermo Fisher collaborates with institutions such as WuXi Diagnostics and Mayo Clinic. Founded in 1956 and headquartered in Waltham, Massachusetts, the company employs approximately 35,000 people and generates over $10 billion in revenue, supporting customers in diverse fields from academic research to healthcare.

Daniella Cramp

Senior Vice President and President

Kent Davidson

Global Vice President Commercial

Glyn Davies

Vice President and GM, Semiconductor Materials and Structural Analysis

Eli Groban

Senior Director of User Experience and Digital Innovation

Alan J. Malus

Executive Vice President

Richard Milne

Vice President and Global Leader of eBusiness

Martina Stenerdal

Director, Country Head Scandinavia (Sweden, Norway, Finland), Clinical Research

Jelto Swaving

Director of Business Management

64 past transactions

Ionpath

Corporate Round in 2022
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

PPD

Acquisition in 2021
PPD, Inc. is a global contract research organization that offers comprehensive drug development and laboratory services to the biopharmaceutical industry. Founded in 1985 and headquartered in Wilmington, North Carolina, PPD operates through two main segments: Clinical Development Services and Laboratory Services. Its clinical development offerings include project management, clinical trial monitoring, regulatory affairs, and post-approval studies, covering various therapeutic areas such as oncology, immunology, and infectious diseases. Additionally, PPD provides laboratory services like bioanalytical testing, vaccine science, and good manufacturing practice. The company serves a diverse clientele, including pharmaceutical and biotechnology firms, medical device manufacturers, and government organizations. With a commitment to accelerating drug development and improving healthcare outcomes, PPD plays a crucial role in bringing innovative therapies to market.

WuXi Diagnostics

Series B in 2021
WuXi Diagnostics is a provider of clinical diagnostic services that focuses on bridging the gap between research and clinical practice. The company offers a range of testing solutions, including screening and early diagnosis, clinical decision support, and prognosis management. By leveraging innovative models, WuXi Diagnostics aims to enhance diagnostic product innovation and generate valuable clinical insights. This approach is designed to improve health outcomes through precision diagnosis and treatment, ultimately benefiting patients and the broader healthcare community.

Mesa Biotech

Acquisition in 2021
Mesa Biotech, Inc. is a company focused on designing, developing, and manufacturing molecular diagnostic tests for infectious diseases. Founded in 2015 and based in San Diego, California, with a satellite laboratory in Santa Fe, New Mexico, Mesa Biotech has created a range of products, including the Accula Dock and various Accula test cassettes for influenza and respiratory syncytial virus. The company utilizes innovative technology that simplifies DNA and RNA testing, combining the convenience of rapid point-of-care tests with the sensitivity and specificity typically associated with laboratory-based molecular diagnostics. This approach allows healthcare professionals to obtain actionable, laboratory-quality results quickly and efficiently.

Henogen

Acquisition in 2021
Henogen is a biotechnology company addressing biomanufacturing issues under the general umbrella "from gene to the clinical product.

Phitonex

Acquisition in 2020
Phitonex, Inc. is developing the next generation of fluorescent labels and instrumentation to advance the fight against disease. Phitonex reagents provide a cost-effective, non-destructive method to obtain more information about critical molecular biomarkers, simplifying experimental design and accelerating the discovery process. As a Duke University spin-out, the company’s co-founders have over 15 years of collaborative experience engineering labels at the molecular level to tailor their fluorescence properties.

Qiagen

Acquisition in 2020
QIAGEN N.V. is a global provider of sample and assay technologies, specializing in transforming biological materials into molecular insights. Founded in 1984 and headquartered in Venlo, the Netherlands, the company offers over 500 proprietary products and automated solutions designed for the extraction, purification, amplification, and interpretation of DNA, RNA, and proteins. Its portfolio includes consumables for sample stabilization and purification, diagnostic kits for human and veterinary molecular diagnostics, and assay technologies that enable the detection of specific targets such as viruses and pathogens. QIAGEN serves a diverse customer base across molecular diagnostics, applied testing, pharmaceuticals, and academia, with a significant portion of its revenue derived from consumables. The company’s automated systems facilitate high-throughput laboratory tasks, enhancing efficiency in molecular analysis. QIAGEN has established collaborations with various organizations to further its product offerings and research initiatives.

Qiagen

Acquisition in 2020
QIAGEN N.V. is a global provider of sample and assay technologies, specializing in transforming biological materials into molecular insights. Founded in 1984 and headquartered in Venlo, the Netherlands, the company offers over 500 proprietary products and automated solutions designed for the extraction, purification, amplification, and interpretation of DNA, RNA, and proteins. Its portfolio includes consumables for sample stabilization and purification, diagnostic kits for human and veterinary molecular diagnostics, and assay technologies that enable the detection of specific targets such as viruses and pathogens. QIAGEN serves a diverse customer base across molecular diagnostics, applied testing, pharmaceuticals, and academia, with a significant portion of its revenue derived from consumables. The company’s automated systems facilitate high-throughput laboratory tasks, enhancing efficiency in molecular analysis. QIAGEN has established collaborations with various organizations to further its product offerings and research initiatives.

Brammer Bio

Acquisition in 2019
Brammer Bio, LLC specializes in developing and manufacturing cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, scale-up, and clinical and commercial supply of drug substances and formulated products. With a focus on autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications, Brammer Bio supports biopharma clients in accelerating the delivery of innovative medicines. The company operates a 45,000 square foot facility in Alachua, Florida, and is expanding with a new 50,000 square foot facility in Lexington, Massachusetts, which will feature large-scale manufacturing suites and laboratories for both clinical and commercial purposes. Established in 2013 and formerly known as Brammer Biopharmaceuticals, Brammer Bio became a subsidiary of Thermo Fisher Scientific in 2019.

HighChem

Acquisition in 2019
HighChem Ltd. designs and develops mass spectrometry software solutions. The company was founded in 1998 and is based in Bratislava, Slovakia. As of June 6, 2019, HighChem Ltd. operates as a subsidiary of Thermo Fisher Scientific Inc.

Brammer Bio

Acquisition in 2019
Brammer Bio, LLC specializes in developing and manufacturing cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, scale-up, and clinical and commercial supply of drug substances and formulated products. With a focus on autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications, Brammer Bio supports biopharma clients in accelerating the delivery of innovative medicines. The company operates a 45,000 square foot facility in Alachua, Florida, and is expanding with a new 50,000 square foot facility in Lexington, Massachusetts, which will feature large-scale manufacturing suites and laboratories for both clinical and commercial purposes. Established in 2013 and formerly known as Brammer Biopharmaceuticals, Brammer Bio became a subsidiary of Thermo Fisher Scientific in 2019.

IntegenX

Acquisition in 2018
IntegenX Inc. specializes in developing human DNA identification solutions, utilizing advanced fluidics, optics, and biochemistry to create automated systems for DNA-based human identity testing. The company’s flagship product, the RapidHIT System, provides a sample-to-answer solution for STR-based human identification, generating standardized DNA profiles from buccal swabs and other samples. Additionally, IntegenX offers the RapidHIT GlobalFiler Express Kit for processing various swab types and crime scene samples, as well as RapidHIT PowerPlex 16 HS kits. The company distributes its products through various international channels, including markets in Europe and Asia. Founded in 2003 and based in Pleasanton, California, IntegenX was previously known as Microchip Biotechnologies, Inc. and rebranded in 2010. As of 2018, it operates as a subsidiary of Thermo Fisher Scientific Inc.

Linkage Biosciences

Acquisition in 2017
Linkage Biosciences is a molecular diagnostics company developing products that hope to improve and expedite complex genetic testing. Their initial focus is on diagnostic products for solid organ and hematopoietic stem cell transplantation where their proprietary technology will have an impact. The company offers human leukocyte antigen testing products used in solid organ and hematopoietic stem cell transplantation, as well as provides pharmacogenomic and autoimmune disease testing and research and genetic marker tests. Lingkage Biosciences was founded in 2004 and is based in

Patheon

Acquisition in 2017
Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services, catering to the pharmaceutical and biotechnology industries globally. The company operates through three primary segments: Drug Product Services, Pharmaceutical Development Services, and Drug Substance Services. It offers a comprehensive range of services, including formulation development, clinical and commercial-scale manufacturing, packaging, and lifecycle management for both small and large molecule drugs. Patheon specializes in various dosage forms, such as solid, semi-solid, liquid, and sterile products. Additionally, it supports clients with specialized capabilities in high-potency and controlled-release formulations. Headquartered in Durham, North Carolina, Patheon was incorporated in 2013 and operates as a subsidiary of Thermo Fisher Scientific.

Core Informatics

Acquisition in 2017
Core Informatics, LLC is a software company that specializes in data management solutions aimed at enhancing scientific discovery and collaboration across various industries, including pharmaceuticals, environmental, and manufacturing. The company provides a range of products, including Core LIMS, a laboratory information management system that streamlines laboratory operations; Core ELN, a solution for managing and sharing experimental data; and Core SDMS, which facilitates automated data capture and instrument integration. Additionally, Core Informatics offers the Platform for Science, a flexible platform-as-a-service that allows organizations to configure and deploy diverse informatics applications efficiently. The company's Core Collaboration platform supports secure data sharing among teams, while Core Connect enables integration with existing IT systems. Incorporated in 2005 and headquartered in Branford, Connecticut, Core Informatics aims to support scientists and business leaders in optimizing their data management practices.

Finesse Solutions

Acquisition in 2017
Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction. Its proprietary Smart technology, which consists of sensors, controllers and software, is designed to optimize the bioproduction workflow.

MTI-GlobalStem

Acquisition in 2016
MTI-GlobalStem has an active research program that utilizes expertise in transfection, neuroscience and stem cell biology to develop and supply scientists with the necessary tools and reagents to help advance new discoveries and developments in the life sciences. Utilizing our intellectual property and know-how, and a specialized team of highly skilled and experienced scientists, we are filling the gap with primary and iPSC-derived neural cells, stem cells and supporting feeder cells, optimized growth media and supplements, and an innovative platform of novel targeted reagents used to deliver nucleic acids into stem cells and neuronal cells with maximum efficiency.

FEI Munich

Acquisition in 2016
FEI Munich is a leader in the field of microscopy, boasting over 60 years of innovation and expertise. The company specializes in the design, manufacturing, and support of high-performance microscopy solutions that operate at micro-, nano-, and picometer scales. Their products facilitate critical discoveries and enhance productivity across various scientific disciplines. Additionally, FEI Munich is involved in the life sciences sector, providing services and products related to fluorescence microscopy, which are essential for fundamental research, applied science, and diagnostics. Through its extensive range of offerings, FEI Munich aims to deliver meaningful insights that contribute to advancements in science and technology.

INEL

Acquisition in 2016
INEL was incorporated in 1984 and converted into a joint venture in 1986 between Lucas Indian Service Ltd, a wholly-owned subsidiary of Lucas-TVS Ltd and MAHLE Electric Drives Japan Corporation, Japan - a company of MAHLE Group, Germany, to manufacture Electronic Ignition Systems for two-wheelers, three wheelers and portable engines. Over the years the company has enlarged its customer base and now supplies to most of the manufacturers of two-wheelers, three wheelers and gensets. Company's net sales for the year ended March, 2015 was Rs.3274 Million (USD 50 Million). INEL makes the entire range of 2/3 wheelers, digital and analog ignition products.

Affymetrix

Acquisition in 2016
Affymetrix specializes in the development and provision of advanced life science tools and diagnostic products that facilitate the analysis of biological systems at the gene, protein, and cell levels. The company's offerings include gene expression products, genotyping services, and tools designed for both clinical diagnostics and research applications. By enabling multiplex and parallel analysis, Affymetrix supports genetic analysis across various sectors, including life sciences and healthcare, thus contributing to the rapid translation of research findings into practical biological applications.

Alfa Aesar

Acquisition in 2015
Alfa Aesar, a part of the Johnson Matthey group, is a prominent manufacturer and supplier of research chemicals, metals, and materials for diverse applications. With over 50 years of experience, the company provides high-purity raw materials essential for research and development. It offers an extensive product line that includes over 45,000 items, ranging from gram-scale catalog products to larger semi-bulk and bulk quantities. The offerings encompass inorganic, organic, and organometallic compounds, pure metals, precious metal compounds, biochemicals, fuel cell products, nanomaterials, and more. Alfa Aesar also specializes in custom manufacturing to meet specific customer needs. The company serves various sectors, including pharmaceutical and electronics industries, as well as academic institutions. Committed to product quality and customer service, Alfa Aesar ensures prompt availability and efficient delivery, with many catalog items available for same-day shipment. Their expertise, coupled with a robust quality assurance process, positions them as a trusted source for high-quality fine chemical products.

Advanced Scientifics

Acquisition in 2015
Advanced Scientifics is a prominent global provider of advanced single-use systems tailored for the Healthcare and Life Sciences sectors. The company specializes in manufacturing customized systems and equipment that facilitate the preparation, processing, diagnostics, storage, and transportation of biopharmaceuticals. Headquartered in Pennsylvania, the company also operates an additional production facility in Matamoros, Mexico, enhancing its capacity to serve clients worldwide. Through its innovative offerings, Advanced Scientifics supports the growing demands of the bioprocessing industry.

Prionics

Acquisition in 2014
One-Stop-Provider in farm animal diagnostics As a world leader in the field of farm animal diagnostics we focus our efforts on meeting the needs of our customers by providing a unique bundle of expertise and diagnostic solutions. While expanding our business along the food value chain, Prionics has successfully grown from a pioneer and global leader in BSE testing to a one-stop-provider for farm animal diagnostics, including diagnostic tests for many zoonoses. Our focus arises from our international clientele and their unique diagnostic issues that challenge us to continuously improve and expand our portfolio and make our solutions available around the world.

Life Technologies

Acquisition in 2014
Life Technologies Corporation operates as a biotechnology tools company. The company's systems, consumables and services enable researchers to accelerate scientific exploration, to discoveries and developments. Life Technologies was created by the combination of [Invitrogen Corporation](/organization/invitrogen) and [Applied Biosystems, Inc.](/organization/applied-biosystems) in November of 2008, and Life Technologies continues to serve its customers under those two well-known brands. Invitrogen is the premier provider of reagents and consumables that are usable across multiple platforms, while Applied Biosystems remains the top provider of systems-based, end-to-end solutions in areas such as PCR, genetic sequencing, and mass spectrometry. The company delivers a range of products and services, including systems, instruments, reagents, and custom services. Its portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications and water testing analysis.

picoSpin

Acquisition in 2012
picoSpin, LLC, based in Boulder, Colorado, was founded in 2010 by Charles E. Miller and a team of scientists and engineers. The company specializes in the development, manufacture, and marketing of miniature nuclear magnetic resonance (NMR) spectrometers. These compact instruments provide chemists with rapid and cost-effective access to analytical spectroscopy, making them valuable for quality analysis, quality control, chemical education, and process development. In addition to NMR spectrometers, picoSpin also produces replacement capillary cartridges and other fluid instruments tailored for the chemical engineering industry.

One Lambda

Acquisition in 2012
One Lambda develops and distributes several lines of histocompatibility (HLA) typing tests utilizing both serological and molecular technologies. One Lambda also manufactures a comprehensive line of antibody detection products, laboratory instrumentation, and computer software that are used to simplify and automate testing procedures and final test evaluations.
Princeton Gamma-Tech Instruments is a leading supplier of X-ray and Gamma-ray Detectors and Spectroscopy systems, portable Radioisotope Identifiers, and portable Chemical Analyzers. We serve a broad customer base in scientific research, industrial materials analysis, and Home Land Security. PGT operates a full customer service and Reachback program, backed by a modern manufacturing and service facility. Princeton Gamma-Tech has been a leader in the field of semiconductor gamma- and X-ray detectors for over 30 years. When General Electric first produced high-purity (intrinsic) germanium crystals in 1972-73, PGT manufactured the first commercial HPGe planar detectors, soon followed by the first HPGe coaxials. Since that time, PGT HPGe detectors have explored outer space, gone to the depths of mines in search of beta-beta decay in enriched germanium, and found uses throughout the world in nuclear power plants, environmental measurements, and aerospace studies.

Doe & Ingalls

Acquisition in 2012
Doe & Ingalls is a distributor of specialty chemicals, catering primarily to the life sciences and microelectronics sectors. The company provides a wide range of products, including cGMP buffer salts and solutions, nutrients, disinfectants, and cleaning solutions for biopharmaceutical processes. In addition to these offerings, Doe & Ingalls supplies photoresists, developers, strippers, edge bead removers, etchants, acids, solvents, and cleaners for electronic component manufacturing, as well as reagents for laboratory testing. Beyond its product distribution, the company aims to enhance supply chain security, robustness, and transparency for its customers by offering complementary supply chain services and market insights.

Intrinsic Bioprobes Inc.

Acquisition in 2011
Intrinsic Bioprobes is a biotechnology company. Moreover, the company is a manufacturer of immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry. Founded in 1996, the company is headquartered in Tempe, Arizona.

Trek Diagnostic Systems

Acquisition in 2011
Trek is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher enable their customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With revenues of nearly $11 billion, they have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries.

Phadia

Acquisition in 2011
At Phadia, they develop, manufacture and market complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. For more than 40 years, they have been focused on delivering results, and they are proud to report that, in that time, they have maintained leadership in allergy testing and become one of the world's leading autoimmune disease test providers. Headquartered in Uppsala, Sweden, their international centre of excellence is at the heart of it all. The site of their strategic management, administration and business development activities, it’s also the home of extensive research and development as well as world-class manufacturing facilities. They also have a site in Southern Sweden, where development of their allergen raw materials takes place. In Freiburg, Germany, a third centre of excellence develops, manufactures and supports diagnostic tests for autoimmune diseases. Recently, a fourth centre of excellence was established in Vienna, Austria, to handle the development and production of assay systems, based on multiplex technology, for both allergy and autoimmunity. Together, these four centres enable us to remain focused on excellence as they respond to the diagnostic needs of the world.

Sterilin

Acquisition in 2011
Sterilin Limited manufactures and supplies disposable plastic products. The company provides disposable plastics, including petri dishes, sample containers, pipettes, and multiwell plates for life science, microbiology, and clinical markets; packaging products, such as a range of regular bottles in HDPE, LDPE, or PP with dispensing, child resistant, and tamper evident closure options; and a range of moulded and extruded silicone products, which include cones, discs, pipette bulbs, sheeting, stoppers, test tube holders, and tubing.

TKA Wasseraufbereitungssysteme

Acquisition in 2010
TKA Wasseraufbereitungssysteme GmbH provides laboratory water purification systems. It offers ion exchange cartridges, reverse osmosis systems, ultrapure water systems, high purity water systems, pretreatment systems, and water softeners, as well as other laboratory equipment and consumables. The company also provides accessories for ion exchange cartridges, mixed-bed resins, reverse osmosis systems, activated carbon filters, ultrapure water systems, measuring instruments, and digital and analog systems.

Dionex

Acquisition in 2010
Dionex Corporation specializes in the development, manufacturing, and servicing of chromatography and extraction systems designed for the separation, isolation, and identification of components within chemical mixtures. The company's chromatography equipment is utilized globally across various sectors, including environmental analysis, life sciences, pharmaceuticals, food and beverage, chemicals, power generation, and electronics. By providing advanced solutions, Dionex enhances productivity for industries critical to global infrastructure and health.

Lomb Scientific

Acquisition in 2010
Lomb Scientific is a major supplier of laboratory consumables, chemicals and instrumentation to the scientific community. Lomb was originally acquired by Walter Parsons in 1984. At the time it was a niche manufacturer and supplier of microscope slides and coverslips. Under Walter's stewardship together with a loyal senior management team, the organisation flourished and the continued growth resulted in several moves to larger, better equipped facilities culminating in the relocation of the Head Office to a purpose built office and warehouse facility. At the same time we established office and warehouse facilities across the rest of Australia and New Zealand. Lomb Scientific's strong organic growth accelerated in recent times with the purchase of Scot Scientific, Fronine and Ajax Finechem. Scot improved our Western Australian coverage for clients. Fronine improved our manufacturing and supply of pathology stains and solvents. Ajax Finechem improved our exclusive company owned brands in chemicals and solvents for our client base. These acquisitions now form the basis of the Lomb group of companies that aspire to support the advance of science better than any other organisation.

Fermentas International

Acquisition in 2010
With origins dating back to the 1970s, Fermentas produced molecular biology products for scientific research. Fermentas grew to be the dominant player in Europe, and sought an experienced life sciences partner to solidify this leading position while helping expand geographically into North America and Asia.

Polychromix

Acquisition in 2010
Polychromix is an advanced communications technology company specializing in modular optical subsystems. It develops and manufactures innovative products for material analysis and chemical sensing, including the PHAZIR, a near-infrared material analyzer. The PHAZIR is designed for various applications such as incoming raw material inspection, quality control and assurance, portable field use, counterfeit product identification, and at-line process control. Polychromix's core technologies facilitate the creation of dynamically configurable optical networks, enhancing its offerings in the field of material analysis and optical communication.

Proxeon

Acquisition in 2010
Proxeon specializes in developing innovative solutions for the field of proteomics, addressing various scientific and technical challenges. With over 15 years of experience in proteomics research, the company has established a strong reputation for creating high-quality products. Proxeon focuses on mass spectrometry, protein analysis, and the design of both hardware and software tailored for proteome analysis. Their offerings include medical devices for sample purification, which enhance proteomic workflows by emphasizing performance, robustness, simplicity, and user-friendliness. By leveraging their extensive expertise, Proxeon contributes to advancing proteomics tools and technologies.

NovaWave Technologies

Acquisition in 2010
NovaWave Technologies (NWT) was founded and incorporated in 2002 with the mission to develop optically-based chemical detection instrumentation for military and civilian markets, including homeland defense, environmental monitoring, metrology, and basic and applied research. Additionally, NWT is developing novel microfluidic systems for biomedical applications in clinical diagnostics and biological agent detection. The team at NWT consists of top-notch scientific, management, and marketing personnel. The company has also formed strategic partnerships with key industry leaders in chemical detection instrumentation and manufacturing. These relationships allow NWT to rapidly produce low cost, high performance sensor systems for worldwide markets. Please contact NWT to discuss partnering or teaming opportunities in our various program areas.

Finnzymes

Acquisition in 2010
Finnzymes works intensively at the leading edge of PCR and transposon technologies. High quality science has been the backbone of the company since its foundation in 1986. Finnzymes' employees are skilled, motivated and creative scientists, dedicated to the company's simple but demanding strategy: we aim to provide new tools of excellent quality to the molecular biology community. Therefore research and development is a continuous process within the company. Production of recombinant enzymes guarantees competitive pricing for our customers and our thorough knowledge in the research field serves as a basis for prompt technical support. In recognition of our work in developing novel enzymes, Finnzymes has been awarded for being the most innovative company in Finland.

Ahura Scientific

Acquisition in 2010
Ahura Scientific Inc. specializes in developing portable, ultra-compact optical systems designed for the immediate identification and authentication of liquid and solid chemical substances. The company’s handheld Raman spectrometers are particularly utilized for raw material identification and finished product authentication within the pharmaceutical and consumer health sectors. Additionally, its products serve critical functions in the identification of chemicals and explosives, material verification, anti-counterfeiting measures, and medical devices. Manufactured in the USA in an ISO 9001-certified facility, Ahura Scientific's offerings are recognized for their exceptional portability and performance, catering to a diverse clientele that includes agencies and companies across the homeland security, life sciences, industrial, and medical markets.

B.R.A.H.M.S.(Brahms)

Acquisition in 2009
B·R·A·H·M·S explores, develops and produces new diagnostic test procedures to improve the diagnosis, and thereby the treatment, of life-threatening illnesses. This takes place with over 400 employees, on the basis of their own patented biomarkers, and leads to medically and economically superior diagnostic insights for patients and medical professionals. B·R·A·H·M·S products reach customers in over 65 countries around the world and are leaders in their specialized markets.

Biolab

Acquisition in 2009
Biolab Limited supplies laboratory products and analytical technologies to clients in Australia and New Zealand. It offers clinical diagnostic testing products, diagnostic imaging products, environmental monitoring and safety products, medical devices and consumables, process monitoring and industrial instruments, laboratory chemicals, laboratory equipment and furniture, life science research technologies, microbiology products, pathology equipment and supplies, and scientific instruments and automation solutions, as well as laboratory plasticware, glassware, and supplies.

ABR--Affinity BioReagents

Acquisition in 2008
ABR--Affinity BioReagents, Inc. manufactures and distributes monoclonal and polyclonal antibodies, and recombinant proteins for the scientific research community. The company offers cell biology products that include apoptosis, cell adhesion and junctions, structure markers, and cytokines; cell signaling products, such as bioactive peptides, G protein-coupled receptors, kinases, membrane receptors, steroid receptors, and steroids hormones; controls, secondaries, and tags that include blocking peptides and secondary antibodies; and muscle biology, nuclear biology, neurobiology, and stem cell biology products. It also provides reagents and immunology services. ABR--Affinity BioReagents, Inc. markets its products through a network of distribution partners in Australia, Austria, Bahrain, Belgium, Brazil, Canada, Chile, China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Latin America, Latvia, Lithuania, Luxembourg, Malaysia, Mercosur, Mexico, the Netherlands, New Zealand, Norway, Poland, Portugal, the Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, the United Arab Emirates, the United Kingdom, the United States, and Vietnam. The company was founded in 1989 and is based in Golden, Colorado. ABR--Affinity BioReagents, Inc. operates as a subsidiary of Pierce Biotechnology Inc.

NanoDrop Technologies

Acquisition in 2007
NanoDrop Technologies specializes in the manufacturing and sale of analytical instruments that utilize patented sample retention technology. Based in Wilmington, Delaware, the company produces micro-volume ultraviolet-visible spectrophotometers and fluorospectrometers, which are designed to analyze small sample volumes of just 1 microliter. These instruments are widely used in biotechnology, pharmaceutical, and life science research laboratories around the world. The innovative sample retention technology was developed in the DuPont Agricultural Genomics Laboratories and has been in operation since 1998, providing researchers with reliable and efficient tools for their analytical needs.
Priority Solutions International provides global supply chain management services. The Company offers logistics services such as warehousing, order management, shipment preparation, international air freight forwarding, and reverse logistics.

Cohesive Technologies

Acquisition in 2007
Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification, and analysis of molecules in bioanalysis. With a strong depth of knowledge in column chemistry, applications, engineering, software development, and quality management, Cohesive Technologies leads the industry in the research, development, and production of LC technologies that accelerate the pace of customers' drug discovery and development efforts.

Flux Instruments

Acquisition in 2007
In 1992 Flux Instruments was founded in the small industrial town of Karlskoga in Sweden. The founders predicted an increasing potential for their novel HPLC pump, based on a radically new concept. Its secret? Hitherto unknown miniaturisation techniques leading to unsurpassed precision and micro flow capabilities. With its R&D department near Munich in Germany and its manufacturing site in Sweden and Switzerland. Technology leadership and precision manufacturing have been given the highest priority. They will continue their innovative strategies and make sure to also fulfill your needs in the years to come. High-Pressure-Liquid-Chromatography has outstanding world-wide growth, probably outperforming all other types of analytical instruments. In combination with MS has, the use of micro bore and capillary columns already are state-of-the-art, other areas in HPLC are likely to follow. The necessity to deliver gradient HPLC flow in the low micro- and even nanoliter range has been their challenge from begin on. Today they offer the No. 1 system for microbore HPLC and have a clear leadership in this market segment. Whether for applications in in life sciences, in proteomics research or in the area of high throughput analysis and fast analysis cycles, the miniaturized design of their instruments is the key to outstanding performance.

Spectronex

Acquisition in 2007
Spectronex is a leading supplier of mass spectrometry, chromatography and surface science instrumentation in Switzerland, Austria, Slovakia and the Czech Republic.

SwissAnalytic Group

Acquisition in 2007
SwissAnalytic Group develops and markets liquid chromatography pumps.

EGS Gauging

Acquisition in 2006
EGS Gauging Inc is one of the world's largest suppliers of measurement and control products for web process applications in the plastics processing and converting industries. They have the resources and the vision to bring their customers into the future with a full complement of innovative web gauging and control systems and services. But the proof is in the numbers: With almost 3000 EGS Gauging systems installed worldwide, and a higher than 75% repeat business rate, the clear message from OEMs and users is that EGS Gauging solutions continue to be the clear choice for quality, reliability, performance and results. From the Americas to Zimbabwe, and more than 50 countries in between, EGS Gauging systems are hard at work delivering top-of-the-line measurement performance for plants of all sizes.

Omega Data Systems

Acquisition in 2006
Netherlands-based Omega Data Systems, developer of the world renowned UniQuant XRF analysis package. UniQuant® is software for use with a sequential X-Ray Fluorescence (XRF) Spectrometer. It enables quantitative elemental analysis of samples without or with the use of standards.

Fisher BioImage

Acquisition in 2006
Fisher BioImage ApS, a life science company, develops and sells assays for monitoring protein translocations and protein interactions in living cells. It provides Redistribution technology, which helps to monitor cell-based protein translocation assays using fluorescent protein reporters. The company offers assays to pharmaceutical and biotechnology companies, as well as to academic groups for basic research.

Clintrak

Acquisition in 2006
Clintrak is a prominent provider of clinical trial labeling, packaging, and logistical services tailored for the pharmaceutical and biotechnology sectors. The company specializes in clinical-trial printing, offering single panel and booklet label design and production. Its booklet label services are particularly valued for their accuracy and cost-effectiveness in managing global, multi-lingual clinical trials. In addition to its core labeling services, Clintrak, along with its subsidiary Acculogix, delivers comprehensive clinical-trial materials and supply-chain management solutions that support all phases of clinical research. By focusing on innovative product designs and rigorous quality control processes, Clintrak aims to enhance the efficiency and reliability of clinical trials worldwide.

Ionalytics Corporation

Acquisition in 2005
Sensitivity, separation and detection are critical success factors in drug discovery. At Ionalytics, they have developed the Ionalytics SelectraTM, a front-end instrument that enhances the performance of mass spectrometers by providing dynamic ion filtering to: - improve efficacy of data - reduce drug development time Based on FAIMS (high-Field Asymmetric waveform Ion Mobility Spectrometry) technology, the Ionalytics Selectra filters and focuses ions within a highly tuned electrical field contained within an electrode set. The result is increased productivity of mass spectrometers in both qualitative and quantitative applications. The Ionalytics team is committed to providing innovative tools to help laboratory professionals determine a drug's potential for treating or curing illness. Comprised of seasoned business leaders, respected scientists and engineers with years of product development and support expertise, their collective talent and experience has resulted in a customer-oriented culture and a high performance instrument that helps bring new drugs to market quicker.

Rupprecht and Patashnick (R&P)

Acquisition in 2005
Since its formation in 1981, R&P has established a global reputation for developing innovative and reliable high performance instrumentation designed to meet the most demanding regulatory applications for continuous particulate monitoring. Headquartered in East Greenbush, New York, R&P will become part of the Air Quality Instruments product line within Thermo's Environmental Instruments division.

Kendro Laboratory Products

Acquisition in 2005
Kendro Laboratory Products is a global leader in providing sample preparation products and services tailored for life sciences, material sciences, and drug discovery applications. The company designs, manufactures, and markets a diverse range of laboratory equipment essential for sample preparation, processing, and storage, primarily utilized in life sciences and clinical laboratories. Kendro's centrifuge products, recognized by brands such as Sorvall and Heraeus, facilitate various applications, including DNA and whole cell separation for biochemistry, molecular biology, and diagnostics. Additionally, the company offers thermal equipment, including ovens, incubators, freezers, and refrigerators, marketed under the Revco and Jewett brands. Beyond equipment, Kendro delivers comprehensive services through a global network of technicians, providing integrated validation services and bio-repositories for sample storage and laboratory relocation management.

Oxoid

Acquisition in 2004
Oxoid, with sales and operations in Europe, North and South America and Australia, is one of the world's leading manufacturers of microbiological culture media and other diagnostic products. Oxoid's products are used in microbiology laboratories, food testing, and biopharmaceutical production and process validation to isolate and identify bacteria or other organisms. Through its rigorous attention to quality and service, Oxoid has earned an unparalleled reputation for helping its customers ensure that their products are free from bacterial contamination. The company is headquartered in Basingstoke, England.

Dharmacon

Acquisition in 2004
Dharmacon, Inc., based in Lafayette, Colorado, specializes in the development and commercialization of RNA oligonucleotide synthesis technologies for the life sciences industry. The company provides a range of products, including gene editing tools, small interfering RNA (siRNA), RNA interference (RNAi) products, cDNAs, and transfection solutions. These offerings are designed to facilitate applications such as gene knockdown, microRNA research, RNAi screening, gene expression analysis, and genome editing. With a strong foundation in chemistry, biology, and bioinformatics, Dharmacon has established itself as a leader in providing high-quality RNA products and custom siRNA design services, enhancing the efficiency of gene silencing technologies. Originally founded in 1995, the company became a subsidiary of Horizon Discovery Group plc in 2017.

Jouan SA

Acquisition in 2003
Jouan is a global supplier of products used by life science researchers in academic, pharmaceutical, biotech, and clinical markets to prepare and preserve laboratory samples. Jouan's offerings include centrifuges, biological safety cabinets, ultra-low temperature freezers, and incubators. The company has also incorporated robotics into many of its products to meet the increased throughput requirements of researchers, and is a leading provider of automated centrifuges, freezers, and incubators. In addition to its own brand name, Jouan's products are sold worldwide under the Precision, NAPCO, Heto, Holten, and ALC brands. Jouan is based in Saint-Herblain, France, and has manufacturing operations in France, Denmark, Italy, the Czech Republic, and the U.S.

Perbio Science

Acquisition in 2003
Perbio Science focuses on proteins. Our products, systems, and services allow our customers who are life science researchers and biopharmaceutical companies to understand and to produce proteins faster, easier, and more economically. The ultimate market driver is the quest for longer, better quality of life for both humans and animals by the development of more and better medicines. Perbio Science is organized into three divisions. The Bioresearch Division provides kits, reagents, and services for identifying, quantifying, purifying and modifying proteins in addition to amidites and nucleotides for nucleic acid-based drugs and diagnostics. The Cell Culture Division is a leader in providing proper nutrition for animal cells in culture, process liquids for protein purification, sterile liquid handling systems, and disposable, sterile liquid processing systems. The Medical Device Division focuses on the ears, nose and throat area, especially voice rehabilitation of laryngectimized patients. The head office of Perbio Science is located in Helsingborg, Sweden. On 31th of March, 2003, Perbio Science had 1314 employees worldwide.

CRS Robotics

Acquisition in 2002
CRS develops laboratory integration hardware and software to control motion control devices (robots). The company designs, manufactures and markets integrated laboratory workstations, laboratory peripheral products and articulated robots for a variety of laboratory and advanced manufacturing processes. Their core competence is the provision of standard automation solutions utilizing advanced proprietary software for the multi-billion dollar world biotechnology and pharmaceutical segments of the global Life Sciences market. CRS advanced software and motion control devices are used for drug discovery, gene sequencing, quality assurance and compound testing. In addition, they supply robot automation products to niche advanced manufacturing and technology markets such as product and materials testing, machine and instrument loading, dispensing and deburring, applications, and for Research and Development and Educational Institutions. CRS is a global company with sales, service and engineering centers throughout the global marketplace.

Keystone Scientific

Acquisition in 2000
Keystone was founded in 1985 by Dr. Richard A. Henry, a highly respected chromatographer with 30 years of experience, and Director of Analytical Laboratories at Penn State University. Dr. Henry is still active in the company as Technical Director, where he sets a high standard for technical support and development of innovative products. Keystone specializes in preparing packed columns for HPLC, SFC and CEC, plus the supplies and accessories that allow columns to be used properly. KSI now occupies various buildings and employs many competent, experienced chemists. The different departments of KSI work together to provide the customer with a high quality product, fast service, excellent customer service and technical support.

Thermo Hypersil-Keystone

Acquisition in 2000
Thermo Hypersil-Keystone LLC manufactures and supplies instrumentation and laboratory equipment such as packed columns and accessories for chromatography; general purpose, base deactivated, reversed and normal phase, and specialty columns for the analysis of proteins, peptides and biomolecules.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.